Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

microRNA Expression and Its Association With Disability and Brain Atrophy in Multiple Sclerosis Patients Treated With Glatiramer Acetate

14 Jun 2022

Abstract excerpt

Background MicroRNAs are small non-coding RNA that regulate gene expression at a post-transcriptional level affecting several cellular processes including inflammation, neurodegeneration and remyelination. Different patterns of miRNAs expression have been demonstrated in multiple sclerosis compared to controls, as well as in different courses of the disease. For these reason they have been postulated as promising...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hydrogen's biological and therapeutic effects
Share to MicroRNA in disease regulation
Share to Multiple Sclerosis Research Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35774792
DOI: 10.3389/fimmu.2022.904683

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

microRNA Expression and Its Association With Disability and Brain Atrophy in Multiple Sclerosis Patients Treated With Glatiramer AcetatePMID 35774792Read ↗

Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesionsSemantic proximity Read ↗

Circulating microRNAs correlate with structural and functional MRI parameters in patients with multiple sclerosisSemantic proximity Read ↗

MicroRNAs in gray and white matter multiple sclerosis lesions: impact on pathophysiologySemantic proximity Read ↗

MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progressionSemantic proximity Read ↗

miRNA Signature in CSF From Patients With Primary Progressive Multiple SclerosisSemantic proximity Read ↗

Regulated microRNAs in the CSF of patients with multiple sclerosisSemantic proximity Read ↗

Evaluation of serum miR-191-5p, miR-24-3p, miR-128-3p, and miR-376c-3 in multiple sclerosis patientsSemantic proximity Read ↗

Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosisSemantic proximity Read ↗

Circulating microRNAs as biomarkers in progressive multiple sclerosisSemantic proximity Read ↗

Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort studySemantic proximity Read ↗

Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple SclerosisSemantic proximity Read ↗

Temporal variability of serum miR-191, miR-223, miR-128, and miR-24 in multiple sclerosis: A 4-year follow-up studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.